Biotech

All Articles

AstraZeneca pays out CSPC $100M for preclinical heart disease medication

.AstraZeneca has paid CSPC Pharmaceutical Group $100 million for a preclinical heart disease medicin...

Zephyrm looks for Hong Kong IPO to cash period 3 cell therapy tests

.Zephyrm Bioscience is actually gusting toward the Hong Kong stock market, submission (PDF) for an I...

Frazier Life Sciences gets $630M for tiny, mid-cap biotechs

.Frazier Daily life Sciences has actually sourced an additionally $630 thousand for its own fund pai...

GigaGen achieves as much as $135M BARDA money to beat botox

.Antitoxin fanatic GigaGen, a subsidiary of Spanish biopharma Grifols, is actually ramping up its te...

GPCR firm Septerna declare IPO on durability of preclinical information

.Septerna will learn how a biotech without "any kind of significant professional data" meals in the ...

Kurma shuts to begin with $154M loot for largest biotech fund as yet

.European VC agency Kurma Partners has revealed its own most current biotech fund, along with 140 th...

Prothena markets one exec while an additional keeps-- Chutes &amp Ladders

.Accept to recently's Chutes &amp Ladders, our roundup of significant management hirings, shootings ...

Editas cashes in on Tip Cas9 licensing civil rights for $57M

.Versus the scenery of a Cas9 license war that rejects to perish, Editas Medicine is cashing in a pi...

Ultragenyx tweaks genetics therapy application to dial up effectiveness

.A minority of individuals taking Ultragenyx Pharmaceutical's Wilson ailment gene therapy UX701 have...

Biopharma unemployment price maintains in Q3: Fierce Biotech review

.As summer season heat energy relies on cool down winds, really hopes that this year would bring wid...